About CorriXR Therapeutics
CorriXR Therapeutics is a private company based in Newark, Delaware, incorporated in 2022 in Delaware. It has reported $6,525,179 raised in one offering on Form D since July 2022. Its chief executive is Deborah Moorad.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 30, 2022 | Jul 15, 2022amended Jan 29, 2024 | $6,525,179of $8.0M target | 4 | $1.6M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CorriXR Therapeutics's Form D filed Jan 29, 2024.
JC
Jeffrey Carper
Director
JB
Jon Brilliant
Executive officer
DM
Deborah Moorad
Chief Executive Officer and director
JN
Janice Nevin
Director
SV
Stella Vnook
Director
EK
Eric Kmiec
Executive officer and director